Universe Pharmaceuticals (UPC) Revenue & Revenue Breakdown
Universe Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$32.31M
Latest Revenue (Q)
$13.84M
Universe Pharmaceuticals Revenue by Period
Universe Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $32.31M | -19.52% |
| 2022-09-30 | $40.14M | -16.34% |
| 2021-09-30 | $47.98M | 56.27% |
| 2020-09-30 | $30.70M | -7.60% |
| 2019-09-30 | $33.23M | 16.54% |
| 2018-09-30 | $28.51M | - |
Universe Pharmaceuticals generated $32.31M in revenue during NA 2023, up -19.52% compared to the previous quarter, and up 113.31% compared to the same period a year ago.
Universe Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $13.84M | -25.05% |
| 2023-03-31 | $18.47M | 15.85% |
| 2022-09-30 | $15.94M | -34.14% |
| 2022-03-31 | $24.20M | 2.17% |
| 2021-09-30 | $23.69M | -2.49% |
| 2021-03-31 | $24.29M | 216.48% |
| 2020-09-30 | $7.68M | - |
| 2020-06-30 | $7.68M | - |
| 2020-03-31 | $7.68M | - |
| 2020-01-31 | $7.68M | -7.60% |
| 2019-09-30 | $8.31M | - |
| 2019-06-30 | $8.31M | - |
| 2019-03-31 | $8.31M | 16.54% |
| 2018-09-30 | $7.13M | - |
| 2018-06-30 | $7.13M | - |
| 2018-03-31 | $7.13M | - |
Universe Pharmaceuticals generated $13.84M in revenue during Q4 2023, up -25.05% compared to the previous quarter, and up 56.98% compared to the same period a year ago.
Universe Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| IMCC | IM Cannabis | $48.80M | $12.06M |
| QLI | Qilian Group | $46.47M | $17.31M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| UPC | Universe Pharmaceuticals | $32.31M | $13.84M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| RGC | Regencell Bioscience | - | - |
UPC Revenue FAQ
What is Universe Pharmaceuticals’s yearly revenue?
Universe Pharmaceuticals's yearly revenue for 2023 was $32.31M, representing a decrease of -19.52% compared to 2022. The company's yearly revenue for 2022 was $40.14M, representing a decrease of -16.34% compared to 2021. UPC's yearly revenue for 2021 was $47.98M, representing an increase of 56.27% compared to 2020.
What is Universe Pharmaceuticals’s quarterly revenue?
Universe Pharmaceuticals's quarterly revenue for Q4 2023 was $13.84M, a -25.05% decrease from the previous quarter (Q2 2023), and a -41.57% decrease year-over-year (Q4 2021). The company's quarterly revenue for Q2 2023 was $18.47M, a 15.85% increase from the previous quarter (Q4 2022), and a -23.98% decrease year-over-year (Q2 2021). UPC's quarterly revenue for Q4 2022 was $15.94M, a -34.14% decrease from the previous quarter (Q2 2022), and a 107.67% increase year-over-year (Q4 2020).
What is Universe Pharmaceuticals’s revenue growth rate?
Universe Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was -32.66%, and for the last 5 years (2019-2023) was -2.77%.